Navigation Links
Common Drug Eases Leg Pain From Walking
Date:5/14/2008

More than half taking naftidrofuryl, a blood vessel medication, improved distances 50%

WEDNESDAY, May 14 (HealthDay News) -- The prescription drug naftidrofuryl eases leg cramps caused by narrowing blood vessels and enables patients to walk farther, according to Belgian researchers.

They reviewed seven studies of 1,266 people with the painful condition called intermittent claudication. Patients who took the typical 200-milligram dose of naftidrofuryl (which relaxes blood vessels) three times a day for six months could walk about 40 percent farther without pain than those who took a placebo. More than half the patients who took the drug improved their walking distance by more than 50 percent, compared to just over one-third of patients who took a placebo. On average, patients who took the drug walked about 93 more yards.

The findings were published in the current issue of the Cochrane Library journal.

"Being able to walk that extra distance and have less pain makes an important, meaningful difference for these patients," study author Dr. Tine De Backer, a cardiologist at the Heart Center and at the Heymans Institute of Pharmacology at Ghent University, said in a prepared statement.

Naftidrofuryl only treats the type of leg cramping that's a symptom of intermittent claudication, but not the cause of the condition, which is peripheral artery disease (PAD), De Backer noted.

PAD is hardening and narrowing of the blood vessels typically associated with diabetes, smoking, high blood pressure, a sedentary lifestyle, elevated blood lipids and aging. PAD affects one in 20 Americans over age 50, according to the U.S. National Heart, Lung, and Blood Institute. People with type 2 diabetes have an especially high risk of PAD and intermittent claudication.

While naftidrofuryl can help patients with intermittent claudication, the review authors emphasized that quitting smoking, getting more ex
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Dutch Tender Offer for Its Common Stock
2. Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness, Increases Patient Safety
3. Problem Gambling Common Among Young Adults
4. Data Show Common Allergy Tests Are Not Interchangeable
5. Common Medications Could Cause Physical Impairment in the Elderly
6. Commonly used medications associated with impaired physical function in older adults
7. NHP Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
8. Pennsylvania Pharmacy Carve-out Poses Risks for Commonwealths Neediest Citizens and Taxpayers, National Organization Testifies
9. Delusions Common in Pediatric ICU
10. Daily aspirin may reduce risk of common type of breast cancer
11. Kidney Care Community Applauds National Taxpayers Unions Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal Common Sense Coverage Reform
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Heat Therapy May Help Prevent Esophageal Cancer 2Health News:New therapy enlists immune system to boost cure rate in a childhood cancer 2Health News:More Living Longer With Advanced Colon Cancer 2Health News:More Living Longer With Advanced Colon Cancer 3Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 2Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 3Health News:William W. Wirtz Allocates $19.5 Million to Northwestern Memorial for Cancer Care and Research 4Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 2Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 3Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 4Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 5Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 6Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 7Health News:Prop. 8 Challenged in Federal Court; Ted Olson & David Boies to Argue Case 8
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 1Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 2Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 3Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 1Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 2Intrinsic Therapeutics Barricaid and Magellan Spine Technologies DART to Drive European Annulus Repair Market 50256 3Horizon Therapeutics Names Dr Jeffrey W Sherman Executive Vice President and Chief Medical Officer 12821 1Horizon Therapeutics Names Dr Jeffrey W Sherman Executive Vice President and Chief Medical Officer 12821 2